Kimberly E. Foreman, PhD
Associate Professor
Education
Ph.D., University of Cincinnati
Tumor Immunologist
Research Interests
Major Research Interests: Notch Signaling in Breast Cancer
Research in our laboratory focuses on Notch signaling in human malignancies, particularly breast cancer. Activated Notch is found in breast cancer tissue samples, and over expression of Notch receptors and ligands in breast cancer is associated with a poor prognosis. These findings suggest Notch may play an important role in breast cancer tumorigenesis, and Dr. Foreman's laboratory is working from the hypothesis that Notch signaling is a potential therapeutic target for cancer treatment. Currently, her laboratory is focused on two areas of investigation: Notch signaling and angiogenesis; Notch signaling in breast tumor initiating cells (also referred to as cancer stem cells).
Publications/Research Listings
Grudzien, P, S Lo, KS Albain, P Robinson, PR Strack, TE Golde, L Miele, and KE Foreman. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. AntiCancer Res 2010 In press
Pannuti, A, K Foreman, P Rizzo, C Osipo, T Golde, B Osborne, and L Miele. Targeting Cancer Stem Cells through Notch Signaling. Clin Can Res 2010 6(12):3141-52
Rizzo, P, C Osipo, K Foreman, T Golde, B Osborne, and L Miele. Rational targeting of Notch signaling in cancer. Oncogene. 2008. 27(38):5124-5131
Curry CL, Reed LL, Broude E, Golde TE, Miele L, and KE Foreman. (2007). Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-kappaB signaling. Mol Cancer Ther. 2007 Jul;6(7):1983-92.
Curry, CL, LL Reed, L Miele, BJ Nickoloff, and KE Foreman (2006).. Notch-independent regulation of Hes-1 expression by c-Jun N-terminal kinase (JNK) signaling in human endothelial cells. Laboratory Investigation. 8:842-852
Curry, CL, LL Reed, TE Golde, L Miele, BJ Nickoloff, and KE Foreman (2005). Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene24:6333-6344.
Hong, Y, K Foreman, J Shin, S Hirakawa, CL Curry, DR Sage, T Liberman, BJ Dezube, JD Fingerroth, and M Detmar (2004). Lymphatic reprogramming of blood vascular endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Nat. Genet 36(7):683-685.
Tang, J, GM Gordon, MG Müller, M Dahiya, and KE Foreman (2003). The KSHV latency associated nuclear antigen (LANA) induces expression of the helix-loop-helix protein, Id-1, in human endothelial cells. J. Virol. 77(10):5975-5984.
Chaturvedi, V, B Bonish, P Bacon, JZ Qin, MF Denning, K Foreman, MO Diaz, J Robinson, and BJ Nickoloff (2003). Role for Id-1 in immunobiology of normal keratinocytes and in basal cell carcinoma.Exp. Dermatol. 12(3):255-60
Search PubMed for a complete listing of Kimberly Foreman's publications.